Healthcare’s AI investment surge is colliding with a familiar constraint: the industry is trying to deploy advanced automation on top of fragmented, aging, and poorly synchronized data systems. That mismatch may explain why so much AI activity feels busy but not transformative.

The Centers for Medicare & Medicaid Services has created the Office of Health Technology and Products, a move that deserves more attention than a routine federal reorganization. The new office formalizes a broader shift inside CMS from technology oversight as a regulatory function to technology strategy as an operating function.

The reported cybersecurity breach affecting more than 1.8 million people connected to NYC Health + Hospitals is a warning about the scale of cyber risk now sitting inside public healthcare infrastructure.

Researchers at the Icahn School of Medicine at Mount Sinai have identified a hidden drug-binding pocket in PKMYT1, a cancer-related kinase involved in cell growth and division. The finding matters because it points toward a more selective route for drug design, while also exposing a central limitation in current AI drug discovery: models can predict known protein structures with striking power, but still miss biologically important states that only appear through experimental work.